The Food and Drug Administration (FDA) is warning consumers to not buy or use Slim-Vie, a supplement marketed for weight loss.
Slim-Vie capsules were found to contain sibutramine, a controlled substance that was withdrawn from the market in October 2010 for safety reasons. Sibutramine may significantly increase blood pressure and/or pulse rate in some patients may pose a significant risk in patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. Taking sibutramine may also result in life-threatening interactions with other drugs a patient is taking.
Slim-Vie capsules are sold on various websites, and possibly in some retail stores.
For more information visit FDA.gov.
This article originally appeared on MPR